|
NEW YORK, NY – March 29, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (Nasdaq: NEO), a company that operates a network of clinical laboratories providing cancer genetics diagnostic testing services.
On March 28, 2022, after the market closed, the Company announced the abrupt resignation of its CEO and warned that its first quarter 2022 revenue and EBITDA would fall short of its prior guidance. Additionally, NeoGenomics withdrew its annual financial guidance issued February 23, 2022. The press release announcing this news states, among other things, that “the Company currently expects revenue for Q1 2022 may be below the low end of its prior guidance of $118 - $120 million and EBITDA for Q1 2022 will be below the low end of its prior guidance of $(15) - $(12) million.” Further, the press release attributed the larger than anticipated EBITDA loss to “higher than anticipated Clinical Services cost of goods sold.”
Following this news, NeoGenomics shares plummeted by more than 30% in midday trading.
If you purchased or otherwise acquired NeoGenomics securities and would like to discuss our investigation, please contact us by emailing
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or by calling (646) 315-9003.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, your rights, or your interests, please contact:
Donald R. Hall
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax: (415) 772-4707
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
